1,183 results on '"Hillege, Hans"'
Search Results
2. Health Professionals' Expectations Versus Experiences of Internet-Based Telemonitoring: Survey Among Heart Failure Clinics
3. What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study
4. A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction
5. Predictors and outcomes of heart failure with mid‐range ejection fraction
6. Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease
7. Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial
8. The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension
9. Serial Measurements of N-Terminal Pro-B-Type Natriuretic Peptide Serum Level for Monitoring Pulmonary Arterial Hypertension in Children
10. Distinct Pathological Pathways in Patients With Heart Failure and Diabetes
11. 52 Genetic Loci Influencing Myocardial Mass
12. A combined clinical and biomarker approach to predict diuretic response in acute heart failure
13. Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration
14. A heart failure phenotype stratified model for predicting 1-year mortality in patients admitted with acute heart failure: results from an individual participant data meta-analysis of four prospective European cohorts
15. Sex differences in patients with repaired tetralogy of Fallot support a tailored approach for males and females: a cardiac magnetic resonance study
16. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction
17. Patient Preferences in the Medical Product Lifecycle
18. Conditional Financing of Drugs in the Netherlands: Past, Present, and Future—Results From Stakeholder Interviews
19. Gene-Age Interactions in Blood Pressure Regulation: A Large-Scale Investigation with the CHARGE, Global BPgen, and ICBP Consortia
20. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction
21. Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction
22. The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF
23. Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure
24. Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF
25. Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation
26. Fontan Circulation over Time
27. What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews
28. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction
29. Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study
30. Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies
31. Serum Potassium Levels and Outcome in Acute Heart Failure (Data from the PROTECT and COACH Trials)
32. Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure — Post-hoc analysis of the PROTECT trial
33. Determinants of temporal changes in galectin-3 level in the general population: Data of PREVEND
34. Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies
35. Acute heart failure in the young: Clinical characteristics and biomarker profiles
36. Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients
37. MicroRNAs relate to early worsening of renal function in patients with acute heart failure
38. The value of telemonitoring and ICT-guided disease management in heart failure: Results from the IN TOUCH study
39. The Fontan circulation and the liver: A magnetic resonance diffusion-weighted imaging study
40. Six-minute walking distance and decrease in oxygen saturation during the six-minute walk test in pediatric pulmonary arterial hypertension
41. A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers.
42. Social media as a tool for assessing patient perspectives on quality of life in metastatic melanoma: a feasibility study
43. Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure
44. Clinical Worsening as Composite Study End Point in Pediatric Pulmonary Arterial Hypertension
45. Off-pump hepatic to azygos connection via thoracotomy for relief of fistulas after a Kawashima procedure: Ten-year results
46. Biochemical Validation of Patient-Reported Symptom Onset Time in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
47. Prognostic factors in pediatric pulmonary arterial hypertension: A systematic review and meta-analysis
48. European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene
49. Should non-cardiovascular mortality be considered in the SCORE model? Findings from the Prevention of Renal and Vascular End-stage Disease (PREVEND) cohort
50. A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.